A new report examines the patient reach efforts of 20 of the world’s largest pharma companies in low- and middle-income countries.
Patient access: How Novartis, Eli Lilly, and other Big Pharmas measure up
A new report examines the patient reach efforts of 20 of the world’s largest pharma companies in low- and middle-income countries.
